Open Philanthropy recommended a grant of $610,000 over two years to Stanford University to support a collaboration between Professor Jeffrey Glenn and Professor James Dahlman, of Georgia Tech, to develop and test novel lipid nanoparticles for use in antiviral drug candidates intended to prevent infections by all beta-coronaviruses and influenza strains. Effective pan-influenza and -coronavirus antiviral drugs could avert hundreds of thousands of deaths annually and minimize the spread of highly infectious and lethal strains of the viruses.
This follows Open Philanthropy's July 2020 support and falls within its work on scientific research, specifically within its interest in science supporting biosecurity and pandemic preparedness.